Skip to main content

Table 1 Descriptive characteristics of the studied population

From: Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women

Variable

Age<65

(n = 171)

65 ≤ Age<75

(n = 185)

75 ≤ Age

(n = 122)

P value

Age (years)

58.0 ± 4.0

69.21 ± 2.9

79.8 ± 3.6

< 0.001

Age of menopause (years)

50.66 ± 4.2

49.89 ± 3.0

50.1 ± 2.9

0.48

BMI (kg/m2)

23.94 ± 3.3

23.99 ± 2.9

23.75 ± 4.1

0.95

Grip strength (kg)

 Left

20.18 ± 3.7

18.74 ± 4.1

15.96 ± 4.2

< 0.001

 Right

22.88 ± 4.4

21.15 ± 4.0

18.12 ± 4.8

< 0.001

 Gait speed (m/s)

1.15 ± 0.19

1.08 ± 0.20

0.87 ± 0.25

< 0.001

Physical exercise (%)

 No

11.8

22.7

48.1

0.008

 Low

39.3

38.8

36.1

0.65

 High

48.9

38.5

15.8

< 0.001

Milk consumption (%)

 No

33.6

38.3

45.7

0.08

 Low

34.3

36.4

38.1

0. 17

 High

32.1

25.3

16.2

0.03

History of fragility facture (%)

11.5

20.3

26.6

0.002

LH (lU/l)

20.43 (15.49–24.16)

17.45 (13.10–26.10)

20.67 (16.15–25.25)

0.453

FSH (lU/l)

53.03 (45.73–64.53)

49.16 (41.51–71.78)

56.59 (50.98–80.66)

0.174

E2 (pmol/l)

40.00 (37.00–45.75)

37.00 (37.00–46.00)

39.00 (37.00–62.75)

0.445

T2 (pg/ml)

0.73 (0.59–0.85)

0.67 (0.56–0.88)

0.99 (0.66–1.20)

0.048

DHEA (ng/ml)

47.08 ± 12.3

40.75 ± 11.5

37.0 ± 11.3

0.009

PTH (pg/ml)

38.6 (32.3–47.4)

40.80 (34.38–47.60)

39.9 (27.75–57.70)

0.637

25OHD (ng/ml)

19.75 (14.9–25.85)

21.05 (15.65–27.65)

23.90 (17.80–27.90)

0.562

CTX (pg/ml)

441.65 ± 198.1

365.75 ± 177.6

369.4 ± 187.4

0.07

PINP (ng/ml)

48.18 ± 17.4

43.97 ± 16.4

40.1 ± 14.5

0.12

Follistatin (ng/ml)

14.45 ± 4.9

15.61 ± 4.5

16.9 ± 4.4

0.19

Myostatin (ng/ml)

4.08 ± 1.6

3.61 ± 1.1

3.4 ± 1.5

0.18

Oxytocin (pg/ml)

508.10 (338.33–1245.42)

380.92 (183.96–722.48)

243.53 (191.99–351.53)

0.008

BDNF (ng/ml)

32.06 ± 11.2

29.51 ± 10.4

27.5 ± 11.1

0.33

BMD (g/cm2)

 total femur

0.822 ± 0.11

0.765 ± 0.11

0.692 ± 0.14

< 0.001

 femoral neck

0.646 ± 0.08

0.612 ± 0.09

0.572 ± 0.12

< 0.001

 lumbar spine

0.802 ± 0.12

0.780 ± 0.12

0.751 ± 0.14

0.24

 WHR (waist/hip)

1.09 ± 0.16

1.11 ± 0.14

1.09 ± 0.13

0.76

 Fat mass (kg)

20.91 ± 4.5

20.73 ± 4.4

19.63 ± 5.2

0.50

 Lean mass (kg)

38.06 ± 4.5

36.82 ± 3.6

34.24v4.4

0.001

 ASMI (kg/m2)

6.25 ± 0.71

6.18 ± 0.56

5.92 ± 0.87

0.13

  1. LH Luteinizing hormone, FSH Follicle stimulating hormone, DHEA Dehydroepiandrosterone, E2 Estradiol, T2 Testosterone, P1NP N-terminal propeptide of type I collagen, CTX Cross-linked C-telopeptide of type I collagen, PTH Parathyroid hormone, 25OHD Serum 25(OH)D, BDNF Brain-derived neurotrophic factor, BMI Body mass index, BMD Bone mineral density, WHR Waist/hip ratio, ASMI Appendicular skeletal mass index